Please assess the completion status of the following clinical trial:

Trial Title: Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female of at least 19 to 65 years old~* Bilaterally symmetrical moderator-to-severe CFL at maximum smile on the FWS as rated by the investigator~Exclusion Criteria:~* Subject with hypersensitivity to the investigational products or their components~* Female subject who are pregnant or lactating~* Subject who are unable to communicate or follow the instructions~* Subject who are not eligible for this study based on the judgment of an investigator

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Botulax (Type: EXPERIMENTAL): Single dose
- Botox (Type: ACTIVE_COMPARATOR): Single dose

Based on this trial design, predict the completion outcome and termination type (if applicable).